Developments for the week
This week, the Fed will reveal details of its plan to cut bond purchases, and the U.S. government will release employment data for October. The U.S. reporting season will continue with earnings and revenue reports from ...
Vaccine sales
J&J Company (JNJ) reported its financial results for the third quarter of 2021 earnings per share exceeded market analysts' forecasts, but revenues fell short of estimates. Sales of COVID-19 vaccines t...
Booster vaccines
CVS and Walgreens pharmacies across the country are administering Pfizer's COVID-19 vaccine boosters to millions of eligible Americans who are most at risk of contracting the virus.
About 6,000 CVS pharmacies and MinuteClinic acros...
2-in-1 vaccine
Moderna's shares have increased dramatically after the announcement of the development of a comprehensive booster vaccine that simultaneously protects against new strains of the COVID-19 virus and seasona...
New York Stock Exchange premarket on Tuesday
Shares in Boeing (NYSE:BA) fell 1% after European budget airline Ryanair, one of the US plane maker's biggest customers, broke off talks over a deal to buy the 737 MAX 10 jets over a disagreement over pri...
The US stock market on Tuesday
Tuesday's trading closed with gains in the oil and gas, commodities and consumer services sectors.
The Dow Jones rose 0.09%, the S&P 500 rose 0.15% and the NASDAQ Composite rose 0.52% at the close of tra...
Share price rises
Moderna shares hit a new high on Monday, ending trading up 17% on news of Australia ordering 25 million Moderna vaccines from COVID-19 and recent research showing greater efficacy from the Delta strain of Moderna vaccine than Pfize...
COVID-19 vaccine
The US administration has purchased a further 200 million doses of coronavirus vaccine from a US company and its German partner BioNTech. This was confirmed by White House press secretary Jennifer ...
Vaccine effectiveness
BioNTech (NASDAQ:BNTX) and Pfizer (NYSE:PFE) shares weakened in Tuesday's premarket as a study in Israel found that in recent weeks their vaccine began to lose effectiveness in preventing the COVID-19 delta strain and the&...
Vaccination of Teenagers
Peru's Ministry of Health has authorised the use of a vaccine from the US pharmaceutical company Pfizer against coronavirus to immunise teenagers aged 12 years and older. This was announced on Monday by the head of the minis...
Vaccine approval application
Novavax will be another major international supplier of vaccines against COVID-19, as trials of its NVX-CoV2373 vaccine have shown an overall effectiveness of 90.4% with good tolerability. Novavax expects coronaviru...
Corporate tax
The G7 countries on Friday formally approved a global minimum corporate tax rate of 15 per cent. This means that multinational companies like Google, Facebook, Apple and others must pay this minimum tax in ...
Shares plummet
Moderna (NASDAQ:MRNA) shares tumbled more than 10% at the opening of trading in New York on Thursday on the back of the Biden administration's decision to support a COVID-19 vaccine intellectual...
Pfizer's earnings
Pharmaceutical company Pfizer (NYSE:PFE) Inc. increased both net income and revenue by 45% in the first quarter.
According to Pfizer press release, its net income in January-March was $4.88 billion, compared to $3.36 billion&...
Vaccination made more accessible to New Yorkers
New York City authorities have expanded access to vaccination against the new coronavirus for the city's entire population, regardless of neighborhood. This was announced on Fr...
FDA approves vaccine
Johnson&Johnson has received approval for emergency use of its vaccine in the US, with the advantages of single-dose administration and standard storage requirements.
Johnson&Johnson receiv...
European markets trade
European stock indices ended Friday's trading lower amid lingering worries about coronavirus vaccines and volatility in US stocks.
The Stoxx Europe 600 composite index of the region's largest companies was down 1.87 per cent ...
Vaccine trial and delivery
Johnson & Johnson is preparing to present the results of the final trials of its COVID-19 vaccine in the next week or two, according to Anthony Fauci, chief medical officer for infectious ...
Delay in supply
The US company has notified Italy of a 29% temporary reduction in the supply of the drug, with the authorities believing it would have a negative impact on the vaccination campaign. Pfizer explained that the delays were due to a prod...
Delivering a vaccine to Africa
Pfizer and BioNTech have offered to supply 50 million doses of the coronavirus vaccine to Africa for health workers. The shipment is due to arrive between March and the...
NEW YORK NEWS
News from GlobalNY.biz is the freshest and most relevant information about high-profile events in the region. The task of the resource's news feed is to convey to readers with maximum accuracy and objectivity information about important events in business, politics, economy, healthcare, culture and other spheres of life in New York.
GlobalNY.biz news is a coverage of economic processes taking place in New York, the latest news of public life, incidents and an overview of political events. New York news is information about the activities of small and medium-sized businesses, the work of housing and communal services and utilities, the implementation of significant projects.
The site's journalists describe not only the life of the region, but also talk about the current state of the US economy. Everything you need to know about innovations in the field of industry and agriculture, economy and power is collected in the "News" section at GlobalNY.biz.
New York news quickly informs the reader, shows the real picture and opens up hot topics. Communication with government structures and business enables us to provide our readers with reliable, information-rich material. The main page of the portal contains the key news of New York!
Alena Potapova
Development Director
